practolol has been researched along with Syndrome in 13 studies
Practolol: A beta-1 adrenergic antagonist that has been used in the emergency treatment of CARDIAC ARRYTHMIAS.
practolol : N-(4-Hydroxyphenyl)acetamide in which the hydrogen of the phenolic hydroxy group is substituted by a 3-(isopropylaminoamino)-2-hydroxypropyl group. A selective beta blocker, it has been used in the emergency treatment of cardiac arrhythmias.
Syndrome: A characteristic symptom complex.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The clinical distribution of an antibody to a metabolite of practolol was investigated, particularly in relation to the oculomucocutaneous syndrome." | 7.66 | Possible role of antibody specific for a practolol metabolite in the pathogenesis of oculomucocutaneous syndrome. ( Amos, HE; Artis, J; Lake, BG, 1978) |
| "Keratoconjunctivitis sicca, conjunctival scarring, fibrosis, metaplasia, and shrinkage developed in 27 patients as an adverse reaction to practolol." | 7.65 | Untoward effects associated with practolol administration: oculomucocutaneous syndrome. ( Wright, P, 1975) |
| " The results for practolol, withdrawn due to the associated oculomucocutaneous syndrome, are given as a single worked example." | 3.73 | A ranked presentation of the MHRA/CSM (Medicines & Health Care Regulatory Agency/Committee on Safety of Medicines) Drug Analysis Print (DAP) data on practolol. ( Mann, RD, 2005) |
| "The clinical distribution of an antibody to a metabolite of practolol was investigated, particularly in relation to the oculomucocutaneous syndrome." | 3.66 | Possible role of antibody specific for a practolol metabolite in the pathogenesis of oculomucocutaneous syndrome. ( Amos, HE; Artis, J; Lake, BG, 1978) |
| "Recognition of the "occulomucocutaneous syndrome" related to practolol administration has caused the safety of other beta-blocking agents to come under close scrutiny." | 3.65 | Practolol and the safety of other beta blockers. ( Sutherland, DC; Wilson, JD, 1976) |
| "Six patients who had surgical treatment for sclerosing peritonitis caused by practolol now have a respiratory disorder characterised by dyspnoea, extensive fibrotic pleural thickening, and lesions in the lung parenchyma." | 3.65 | Respiratory disease associated with practolol therapy. ( Barritt, DW; Davies, JD; Eltringham, WK; Griffiths, DA; Jackson, LK; Laszlo, G; Marshall, AJ; Read, AE, 1977) |
| "Keratoconjunctivitis sicca, conjunctival scarring, fibrosis, metaplasia, and shrinkage developed in 27 patients as an adverse reaction to practolol." | 3.65 | Untoward effects associated with practolol administration: oculomucocutaneous syndrome. ( Wright, P, 1975) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 12 (92.31) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (7.69) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mann, RD | 1 |
| George, CF | 1 |
| Sutherland, DC | 1 |
| Wilson, JD | 1 |
| Behan, PO | 1 |
| Behan, WM | 1 |
| Zacharias, FJ | 1 |
| Nicholls, JT | 1 |
| Bartsch, P | 1 |
| Madsen, SN | 1 |
| Sondergaard, J | 1 |
| Marshall, AJ | 1 |
| Eltringham, WK | 1 |
| Barritt, DW | 1 |
| Davies, JD | 1 |
| Griffiths, DA | 1 |
| Jackson, LK | 1 |
| Laszlo, G | 1 |
| Read, AE | 1 |
| Mackie, RM | 1 |
| Milne, JA | 1 |
| Amos, HE | 1 |
| Lake, BG | 1 |
| Artis, J | 1 |
| Wright, P | 1 |
| Langslet, A | 1 |
| Sorland, SJ | 1 |
| Sahn, SA | 1 |
| van Durme, JP | 1 |
| van den Bogaert-van Heesvelde, AM | 1 |
| Blancquaert, A | 1 |
2 reviews available for practolol and Syndrome
| Article | Year |
|---|---|
Perspectives in dermatology: Great Britain (1972-1974).
Topics: Aging; Animals; Dermatitis Herpetiformis; Dermatology; Drug Eruptions; Freeze Fracturing; Humans; Im | 1975 |
Immunologic diseases of the pleura.
Topics: Adult; Aged; Bromocriptine; Cardiac Surgical Procedures; Collagen Diseases; Dantrolene; Female; Gran | 1985 |
11 other studies available for practolol and Syndrome
| Article | Year |
|---|---|
A ranked presentation of the MHRA/CSM (Medicines & Health Care Regulatory Agency/Committee on Safety of Medicines) Drug Analysis Print (DAP) data on practolol.
Topics: Adrenergic beta-Antagonists; Adverse Drug Reaction Reporting Systems; Consumer Product Safety; Eye D | 2005 |
Drugs causing intestinal obstruction: a review.
Topics: Anticoagulants; Contraceptives, Oral; Erythema; Female; Humans; Intestinal Obstruction; Keratoconjun | 1980 |
Practolol and the safety of other beta blockers.
Topics: Adrenergic beta-Antagonists; Aged; Antibodies, Antinuclear; Drug Eruptions; Eye Diseases; Female; Hu | 1976 |
Immunological abnormalities in patients who had the oculomucocutaneous syndrome associated with practolol therapy.
Topics: Adult; Aged; Autoantibodies; Autoimmune Diseases; Coronary Disease; Drug Eruptions; Eye Diseases; Fe | 1976 |
Chronic obstructive lung disease after practolol.
Topics: Adult; Chronic Disease; Conjunctivitis; Dyspnea; Female; Humans; Lung Diseases, Obstructive; Practol | 1977 |
Cyclic nucleotides, practolol, and the peritoneum.
Topics: Cyclic AMP; Cyclic GMP; Humans; Peritonitis; Practolol; Syndrome | 1977 |
Respiratory disease associated with practolol therapy.
Topics: Aged; Dyspnea; Female; Heart Diseases; Humans; Male; Middle Aged; Peritonitis; Pleural Diseases; Pra | 1977 |
Possible role of antibody specific for a practolol metabolite in the pathogenesis of oculomucocutaneous syndrome.
Topics: Antibodies; Antibody Specificity; Drug Eruptions; Eye Diseases; Humans; Mucous Membrane; Practolol; | 1978 |
Untoward effects associated with practolol administration: oculomucocutaneous syndrome.
Topics: Adult; Aged; Blindness; Cochlea; Conjunctiva; Ear Diseases; Eye Diseases; Female; Humans; Keratoconj | 1975 |
Surdocardiac syndrome of Jervell and Lange-Nielsen, with prolonged QT interval present at birth, and severe anaemia and syncopal attacks in childhood.
Topics: 1-Propanol; Anemia, Hypochromic; Child; Child, Preschool; Deafness; Electrocardiography; Female; Hea | 1975 |
[Continuous recording of the electrocardiogram in the diagnosis and treatment of dysrhythmia in children].
Topics: Adrenergic beta-Antagonists; Arrhythmias, Cardiac; Deafness; Diagnosis, Computer-Assisted; Electroca | 1974 |